Novo Nordisk ADR (NYSE: NVO) is -26.02% lower on its value in year-to-date trading and has touched a low of $62.37 and a high of $148.15 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NVO stock was last observed hovering at around $62.55 in the last trading session, with the day’s gains setting it 1.09%.
Currently trading at $63.64, the stock is -12.87% and -21.01% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 14.54 million and changing 1.74% at the moment leaves the stock -41.47% off its SMA200. NVO registered -48.66% loss for a year compared to 6-month loss of -44.70%. The firm has a 50-day simple moving average (SMA 50) of $80.5698 and a 200-day simple moving average (SMA200) of $108.72155.
The stock witnessed a -26.99% gain in the last 1 month and extending the period to 3 months gives it a -27.39%, and is -8.35% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.11% over the week and 2.80% over the month.
Novo Nordisk ADR (NVO) has around 76302 employees, a market worth around $214.10B and $42.09B in sales. Current P/E ratio is 19.39 and Fwd P/E is 13.30. Profit margin for the company is 34.81%. Distance from 52-week low is 2.04% and -57.04% from its 52-week high. The company has generated returns on investments over the last 12 months (45.25%).
with sales reaching $79.17B over the same period.The EPS is expected to grow by 23.46% this year, but quarterly earnings will post 20.64% year-over-year. Quarterly sales are estimated to grow 21.15% in year-over-year returns.
Novo Nordisk ADR (NVO) Top Institutional Holders
1934.0 institutions hold shares in Novo Nordisk ADR (NVO), with institutional investors hold 10.27% of the company’s shares. The shares outstanding are 3.37B, and float is at 3.36B with Short Float at 0.38%. Institutions hold 10.27% of the Float.
The top institutional shareholder in the company is JENNISON ASSOCIATES LLC with over 21.22 million shares valued at $3.03 billion. The investor’s holdings represent 0.476% of the NVO Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 19.49 million shares valued at $2.78 billion to account for 0.4373 of the shares outstanding. The other top investors are MORGAN STANLEY which holds 14.61 million shares representing 0.3278% and valued at over $2.09 billion, while BANK OF AMERICA CORP /DE/ holds 0.3183 of the shares totaling 14.19 million with a market value of $2.03 billion.
Novo Nordisk ADR (NVO) Insider Activity
#####
